user

The Efficacy of Teneligliptin with Metformin in Drug-Naive Type 2 Subjects

被引：2
|
作者：
Chudasama, Dipak B.
Saboo, Banshi D.
Panchal, Dharmendra
Patel, Feny
Saiyed, Mahira
Hasnani, Dhruvi
Chavda, Vipul
Chandarana, Hardik
Goklani, Rutul
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1205-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naive Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
    Yoon, Kun Ho
    Shin, Jeong Ah
    Kwon, Hyuk Sang
    Lee, Seung Hwan
    Min, Kyung Wan
    Ahn, Yu Bae
    Yoo, Soon Jib
    Ahn, Kyu Jeung
    Park, Sung Woo
    Lee, Kwan Woo
    Sung, Yeon Ah
    Park, Tae Sun
    Kim, Min Seon
    Kim, Yong Ki
    Nam, Moon Suk
    Kim, Hye Soon
    Park, Ie Byung
    Park, Jong Suk
    Woo, Jeong Taek
    Son, Ho Young
    DIABETES & METABOLISM JOURNAL, 2011, 35 (01) : 26 - 33
  • [22] The efficacy of pioglitazone compared to metformin in drug naive patients with Type 2 diabetes.
    Lenton, S
    Schernthaner, G
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    DIABETOLOGIA, 2003, 46 : A287 - A287
  • [23] Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naive patients with type 2 diabetes: initial triple study
    Lim, Soo
    Ku, Eu Jeong
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Jie-Eun
    Kim, Kyoung Min
    Davies, Melanie J.
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [24] Canagliflozin as an Initial Therapy in Drug-Naive Subjects with Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in its Glycemic Efficacy
    Kutoh, Eiji
    Wada, Asuka
    Murayama, Teruma
    Takizawa, Yui
    DRUGS IN R&D, 2017, 17 (02) : 313 - 320
  • [25] Initial Combination Therapy with Metformin Plus Colesevelam in Drug-Naive Hispanic Patients with Early Type 2 Diabetes
    Rosenstock, Julio
    Hernandez-Triana, Eric
    Handelsman, Yehuda
    Misir, Soamnauth
    Jones, Michael R.
    Nagendran, Sukumar
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 7 - 13
  • [26] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [27] Fixed dose combinations of empagliflozin and linagliptin for 52 weeks in drug-naive subjects with type 2 diabetes
    Lewin, A.
    DeFronzo, R.
    Patel, S.
    Liu, D.
    Kaste, R.
    Woerle, H. J.
    Broedl, U. C.
    DIABETOLOGIA, 2014, 57 : S346 - S347
  • [28] A Comparative Study of Safety and Efficacy of Metformin Monotherapy Against Teneligliptin and Metformin in Type 2 Diabetes Mellitus
    Poornima, R.
    Brigida, S.
    Elizabeth, Arul Amutha
    Soujania, G.
    Lella, Tanuja
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (02) : 7 - 12
  • [29] Empagliflozin monotherapy in drug-naive patients with Type 2 diabetes
    Roden, M.
    Weng, J.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Stella, P.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 89 - 89
  • [30] Effects of Rosiglitazone/Metformin FDC on BMD after 80 Weeks of Treatment in Drug-Naive T2DM Subjects
    Bilezikian, John
    Borges, Joao
    Panelo, Araceli
    Chang, Chewn-Tzuei
    Nino, Antonio
    Adams, Patricia
    Jones, Angela
    Acusta, Andre
    Kolatkar, Nikheel
    Cobitz, Alexander
    Fitzpatrick, Lorraine
    DIABETES, 2010, 59 : A105 - A106
12345